Related Experiment Videos
Evaluating candidate autoantigens in rheumatoid arthritis
1Kennedy Institute of Rheumatology, Hammersmith, London, UK.
Springer Seminars in Immunopathology
|December 4, 1998
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis.
Arthritis research & therapy·2020
Improving medication adherence in rheumatoid arthritis (RA): a pilot study.
Psychology, health & medicine·2015
Exploring the signalling pathways promoting T cell effector responses in chronic inflammation.
Modern rheumatology·2014
Precipitating and perpetuating factors of rheumatoid arthritis immunopathology: linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis.
Best practice & research. Clinical rheumatology·2011
Activating and inhibitory FcgammaRs in autoimmune disorders.
Springer seminars in immunopathology·2006
Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.
Springer seminars in immunopathology·2006
Fcepsilon- and Fcgamma-receptor signaling in diseases.
Springer seminars in immunopathology·2006
Fc gamma receptors and cancer.
Springer seminars in immunopathology·2006
FcgammaRII and multi-system autoimmune disease.
Springer seminars in immunopathology·2006
Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.
Springer seminars in immunopathology·2006
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026